Lead Biologics

imbiologics

The company develops antibody therapeutics for autoimmune diseases and cancer, providing these biological medicines to pharmaceutical firms and healthcare providers.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

SELECXINE

Selecxine develops antibody-cytokine conjugates for cancer treatment, providing these immunotherapeutic biologics to the pharmaceutical industry and clinical research institutions.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

immunos

This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

Bioinvent International

This company develops antibody-based immunotherapies for cancer patients and provides contract manufacturing services to pharmaceutical firms and academic institutions.